Oscillating CD8(+) T cell effector functions after antigen recognition in the liver

Area of Science:

• Immunology
• Hepatology
• Virology

Background:

• Hepatitis B virus (HBV) infection triggers an immune response involving CD8(+) cytotoxic T lymphocytes (CTLs).
• Adoptive transfer of HBV-specific CTLs into HBV transgenic mice can control viral replication but also cause hepatitis.

Purpose of the Study:

• To investigate how antigen recognition influences the activation, function, kinetics, and localization of transferred CTLs in the liver.
• To understand the dynamic interplay between CTL effector functions and antigen stimulation during HBV infection.

Main Methods:

• Adoptive transfer of HBV-specific CD8(+) CTLs into HBV transgenic mouse models.
• Analysis of CTL activation phenotype, effector functions (cytolytic and noncytolytic), proliferation, and contraction kinetics.
• Assessment of T cell compartmentalization within the liver and correlation with PD-1 expression.

Main Results:

• Antigen recognition in the liver drives asynchronous and oscillatory regulation of CTL effector functions and expansion-contraction kinetics.
• PD-1 upregulation is associated with these dynamic CTL responses.
• Noncytolytic and cytolytic functions evolve distinctly in response to sustained antigen recognition.

Conclusions:

• Oscillatory CTL responses in the liver may represent an optimal strategy to balance viral clearance and minimize immunopathology.
• Dyssynchrony in CTL activation, effector function, and contraction can contribute to viral persistence and chronic liver disease.
• Understanding these dynamics is crucial for developing effective immunotherapies for chronic HBV infection.